22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial OfficerGlobeNewsWire • 06/03/20
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP ApplicationGlobeNewsWire • 04/17/20
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory SmokingGlobeNewsWire • 03/04/20
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm UseGlobeNewsWire • 03/04/20
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory CommitteeGlobeNewsWire • 12/23/19
FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol CigarettesGlobeNewsWire • 12/17/19
22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.GlobeNewsWire • 12/03/19
22nd Century Group Inc (XXII) President and CEO Clifford B Fleet Bought $190,000 of SharesGuruFocus • 08/28/19
22nd Century Group, Inc. (XXII) CEO Cliff Fleet on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19